Research output per year
Research output per year
Personal profile
Headline
CLINICAL INSTRUCTOR / Dermatology
Biography
Dr. Napatalung earned her B.S. degree Summa Cum Laude in2005 from Middle Tennessee State University and her M.D. from University ofTennessee Health Science Center in 2012, earning the Albright Armstrong RiceMerit Scholarship. She did a one-year internship at The Mayo School ofGraduate Medical Education prior to entering her dermatology residency also atThe Mayo School of Graduate Medical Education, where she served as chiefresident and completed in 2016. Since 2017 Dr. Napatalung has served as aMedical Director of Global Medical Affairs for Pfizer where she leads the JAK3alopecia areata and vitiligo programs. Prior to Pfizer Dr. Napatalungserved as Dermatologist at Illinois Dermatology Institute in Chicago, Illinois.
Fingerprint
Dive into the research topics where Lynne Napatalung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Anderson, S., Cavaletti, G., Hood, L. J., Polydefkis, M., Herrmann, D. N., Rance, G., King, B., McMichael, A. J., Senna, M. M., Kim, B. S., Napatalung, L., Wolk, R., Zwillich, S. H., Schaefer, G., Gong, Y., Sisson, M. & Posner, H. B., Aug 2024, In: Pharmacology Research and Perspectives. 12, 4, e1204.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
Davis, K. L., Messenger, A., Galván, S. V., Tran, H., Napatalung, L., Hanson, K. A. & Law, E. H., 18 Mar 2024, In: SKIN: Journal of Cutaneous Medicine. 8, 2, p. S395Research output: Contribution to journal › Article › peer-review
Open Access -
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
Sørensen, S. B. T., George, P., Jagun, O., Wolk, R., Napatalung, L., Zwillich, S. H., Iversen, L. & Ehrenstein, V., Apr 2024, In: Dermatology and Therapy. 14, 4, p. 993-1006 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata
King, B., Zhang, X., Harcha, W. G., Szepietowski, J. C., Shapiro, J., Lynde, C., Mesinkovska, N. A., Zwillich, S. H., Napatalung, L., Wajsbrot, D., Fayyad, R., Freyman, A., Mitra, D., Purohit, V., Sinclair, R. & Wolk, R., 1 Oct 2023, In: Immunotherapy. 15, 14, p. 1093-1103 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
King, B., Zhang, X., Harcha, W. G., Szepietowski, J. C., Shapiro, J., Lynde, C., Mesinkovska, N. A., Zwillich, S. H., Napatalung, L., Wajsbrot, D., Fayyad, R., Freyman, A., Mitra, D., Purohit, V., Sinclair, R. & Wolk, R., 6 May 2023, In: The Lancet. 401, 10387, p. 1518-1529 12 p.Research output: Contribution to journal › Article › peer-review
Open Access61 Scopus citations
Press/Media
-
-
New Safety and Efficacy Data of Ritlecitinib for Alopecia Areata Published in The Lancet
1/04/23
1 item of Media coverage
Press/Media